Skip to content
Reflections of yellow marbles on metal holders
Reflections of yellow marbles on metal holders

Food and Cosmetics

Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.

Our Life Sciences team has experience of advising many cosmetic and food companies, including Cargill, LVMH Perfumes and Cosmetics, Primark, United Biscuits, McDonalds, Heineken, Kraft Foods Inc, Nestlé, British Sugar and Heinz, among others. We have advised on issues including health claims, composition and labelling requirements, and various marketing issues. Our lawyers know the issues the industry faces and understand how to deal with them. The team has the added benefit of being fully integrated into Allen & Overy’s broader Life Sciences team and benefits from insights and expertise from our dedicated Life Sciences regulatory group.

News & insights

Bird's eye view of a major intersection and suspension bridge at night

News: 10 JULY 2020

Allen & Overy advises on Immunotech Biopharm’s global offering and listing on the Hong Kong Stock Exchange

Allen & Overy has advised the joint sponsors on the global offering and listing of shares of Immunotech Biopharm Ltd (Immunotech Biopharm) on the Hong Kong Stock Exchange under Chapter 18A of the…

Read more
A drop of liquid falling into a test tube

Publications: 08 JULY 2020

Pipeline gaps and digital will drive life sciences deals

Often seen as a safe haven sector in times of crisis, the life sciences have not only been centre stage during the Covid-19 coronavirus crisis but are riding it out well.

Read more
A major road junction with very few cars

Publications: 08 JULY 2020

China maintains outward-looking approach

The Covid-19 coronavirus crisis has slowed Chinese deal activity. Activity remains sluggish even though the country is emerging from the crisis earlier than the rest of the world.

Read more
LCD stock exchange screen showing the words index and close

Publications: 08 JULY 2020

A market utterly transformed, as M&A deals stall

The Covid-19 coronavirus pandemic has brought the global M&A market to a juddering halt and is likely to radically change dealmaking for the foreseeable future.

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2020

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.